grantDOI: https://doi.org/10.48105/CTF.CTF-2023-01-009.pc.gr.172011 studyName: Co-Targeting HMGB1 and EGF signaling for the treatment of NF2 and associated hearing loss dataStatus: Under Embargo initiative: Young Investigator Award studyLeads: Zhenzhen Yin studyStatus: Withdrawn diseaseFocus: Neurofibromatosis type 2 institutions: Massachusetts General Hospital fundingAgency: CTF relatedStudies: true studyFileviewId: syn52676861 syn52676852 syn53183758 syn52676853 syn52676861 syn52676854 syn63813206
Drop files to upload
Co-Targeting HMGB1 and EGF signaling for the treatment of NF2 and associated hearing loss page is loading…